Related Experiment Video
Updated: May 23, 2026
03:40
Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
Hematopoietic stem cell transplantation in Europe. Differences between Eastern and Western countries
Alvaro Urbano-Ispizua1, Helen Baldomero, Alois Gratwohl
1Institute of Hematology and Oncology, Hospital Clinic Barcelona, University of Barcelona, José Carreras Institute of Research, Barcelona, Spain. aurbano@ub.edu
Hematology (Amsterdam, Netherlands)
|April 18, 2012
Summary
Hemopoietic stem cell transplantation (HSCT) use varies geographically, influenced by economic factors. Understanding these disparities is crucial for healthcare resource allocation and optimizing patient access to this high-cost therapy.
Area of Science:
- Hematology
- Transplantation Medicine
- Health Economics
Background:
- Hemopoietic stem cell transplantation (HSCT) is a globally increasing medical procedure.
- Significant geographical disparities exist in HSCT utilization within continents.
- Previous research highlighted economic factors as key drivers of these regional differences.
Purpose of the Study:
- To analyze the geographical distribution of HSCT procedures.
- To investigate the economic factors influencing HSCT utilization.
- To provide insights for rational decision-making in healthcare resource allocation.
Main Methods:
- Review of existing literature on HSCT geographical distribution.
- Analysis of economic data related to HSCT procedures.
- Comparative study of HSCT utilization across different regions.
Main Results:
- HSCT use is not uniformly distributed geographically.
- Economic factors significantly correlate with variations in HSCT rates.
- High costs present a challenge for healthcare institutions and public health.
Conclusions:
- Understanding geographical and economic disparities in HSCT is vital.
- Informed decision-making requires insights into HSCT technology and utilization factors.
- Addressing resource limitations is essential for equitable patient access to optimal therapy.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...